These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12605446)

  • 21. GNAS mutations and heterotopic ossification.
    Bastepe M
    Bone; 2018 Apr; 109():80-85. PubMed ID: 28889026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somitic disruption of GNAS in chick embryos mimics progressive osseous heteroplasia.
    Cairns DM; Pignolo RJ; Uchimura T; Brennan TA; Lindborg CM; Xu M; Kaplan FS; Shore EM; Zeng L
    J Clin Invest; 2013 Aug; 123(8):3624-33. PubMed ID: 23863715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deficiency of the alpha-subunit of the stimulatory G protein and severe extraskeletal ossification.
    Eddy MC; Jan De Beur SM; Yandow SM; McAlister WH; Shore EM; Kaplan FS; Whyte MP; Levine MA
    J Bone Miner Res; 2000 Nov; 15(11):2074-83. PubMed ID: 11092390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive osseous heteroplasia.
    Miller ES; Esterly NB; Fairley JA
    Arch Dermatol; 1996 Jul; 132(7):787-91. PubMed ID: 8678571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans.
    Lebrun M; Richard N; Abeguilé G; David A; Coëslier Dieux A; Journel H; Lacombe D; Pinto G; Odent S; Salles JP; Taieb A; Gandon-Laloum S; Kottler ML
    J Clin Endocrinol Metab; 2010 Jun; 95(6):3028-38. PubMed ID: 20427508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gα
    Cong Q; Xu R; Yang Y
    Curr Top Dev Biol; 2019; 133():281-307. PubMed ID: 30902256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal abnormalities and extra-skeletal ossification in mice with restricted Gsalpha deletion caused by a renin promoter-Cre transgene.
    Castrop H; Oppermann M; Mizel D; Huang Y; Faulhaber-Walter R; Weiss Y; Weinstein LS; Chen M; Germain S; Lu H; Ragland D; Schimel DM; Schnermann J
    Cell Tissue Res; 2007 Dec; 330(3):487-501. PubMed ID: 17922144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive Osseous Heteroplasia: A Rare Case Report.
    Sahu K; Rout AN; Mohapatra L; Mohanty P
    Indian Dermatol Online J; 2020; 11(4):604-606. PubMed ID: 32832452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The genetic basis of progressive osseous heteroplasia.
    Jüppner H
    N Engl J Med; 2002 Jan; 346(2):128-30. PubMed ID: 11784882
    [No Abstract]   [Full Text] [Related]  

  • 30. Endochondral ossification in a case of progressive osseous heteroplasia in a young female child.
    Schrander DE; Welting TJ; Caron MM; Schrander JJ; van Rhijn LW; Körver-Keularts I; Schrander-Stumpel CT
    J Pediatr Orthop B; 2014 Sep; 23(5):477-84. PubMed ID: 24626099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of two new, highly polymorphic loci adjacent to GNAS1 on chromosome 20q13.3.
    Bastepe M; Jüppner H
    Mol Cell Probes; 2000 Aug; 14(4):261-4. PubMed ID: 10970731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pseudopseudohypoparathyroidism vs progressive osseous heteroplasia in absence of family history].
    Pereda A; González Oliva E; Riaño-Galán I; Pérez de Nanclares G
    Med Clin (Barc); 2015 Nov; 145(10):e25-7. PubMed ID: 25865609
    [No Abstract]   [Full Text] [Related]  

  • 33. Progressive osseous heteroplasia caused by a mosaic GNAS mutation.
    Pereda A; Martos-Tello JM; Garin I; Errea-Dorronsoro J; Perez de Nanclares G
    Clin Endocrinol (Oxf); 2018 Jun; 88(6):993-995. PubMed ID: 29464731
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic variation of the extra-large stimulatory G protein alpha-subunit leads to Gs hyperfunction in platelets and is a risk factor for bleeding.
    Freson K; Hoylaerts MF; Jaeken J; Eyssen M; Arnout J; Vermylen J; Van Geet C
    Thromb Haemost; 2001 Sep; 86(3):733-8. PubMed ID: 11583302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor-mediated adenylyl cyclase activation through XLalpha(s), the extra-large variant of the stimulatory G protein alpha-subunit.
    Bastepe M; Gunes Y; Perez-Villamil B; Hunzelman J; Weinstein LS; Jüppner H
    Mol Endocrinol; 2002 Aug; 16(8):1912-9. PubMed ID: 12145344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative functions of Gαs and its extra-large variant XLαs in the endocrine system.
    Bastepe M
    Horm Metab Res; 2012 Sep; 44(10):732-40. PubMed ID: 22730013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Paternal GNAS mutations: Which phenotypes? What genetic counseling?].
    Kottler ML
    Ann Endocrinol (Paris); 2015 May; 76(2):105-9. PubMed ID: 25952723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive osseous heteroplasia controlled by intravenous administration of pamidronate.
    Hou JW
    Am J Med Genet A; 2006 Apr; 140(8):910-3. PubMed ID: 16532474
    [No Abstract]   [Full Text] [Related]  

  • 39. Picture of the month. Diagnosis: Osteoma cutis associated with pseudohypoparathyroidism Type 1a.
    Darling MJ; Bauer A
    Arch Pediatr Adolesc Med; 2008 Nov; 162(11):1091; discussion 1092. PubMed ID: 18981359
    [No Abstract]   [Full Text] [Related]  

  • 40. Congenital plate-like osteoma cutis of the forehead: an atypical presentation form.
    Tresserra L; Tresserra F; Grases PJ; Badosa J; Tresserra M
    J Craniomaxillofac Surg; 1998 Apr; 26(2):102-6. PubMed ID: 9617674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.